Oral+Presentation+Case+9

= Oral Presentation Case 9 =

//Five years ago, a number of multinational pharmaceutical companies (Big Pharma) took the South African Government to court in an attempt to stop the importation and distribution of cheap drugs to treat HIV/AIDS. Although this attempt was unsuccessful, attention of Big Pharma has now moved to India, a country with a huge pharmaceutical industry. The current impetus of Big Pharma is to challenge the Indian government’s patent law‐ a law which protects the production by Indian companies of cheap generic medicines ‐ medicines that are used by millions of people around the world. Explore the ethical issues raised.//

Stakeholders and values
big drug companies and novartis - want more money, have a right to make profit, wants to increase market share, recoup r and d costs indian government- higher employment, better economy, higher GDP, better healthcare for its people third world countries - benefit from low drug cost, greater assessibility, more employment and productivity, better economy, lift out of poverty

Resources
[|Setback for Novartis in India Over Drug Patent] [|HEALTH-INDIA: Novartis Patents Case Far From Dead]

//Ayumi//